Novartis Spends US$8.7 B on Gene Therapy Biotech AveXis
By Natasha Piper
Pharma Deals Review: Vol 2018 Issue 4 (Table of Contents)
Published: 19 Apr-2018
DOI: 10.3833/pdr.v2018.i4.2320 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Just days after agreeing to sell its stake in its consumer healthcare joint venture to GlaxoSmithKline for US$13 B, Novartis has agreed to spend US$8...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS